Clinical Trials
3 trialsNCT07123493 2026-01-28
Engineered T-Cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors
Beijing GoBroad Hospital
Phase EARLY_PHASE1 Terminated
NCT04034446 2025-06-03
CD19-CD22 Chimeric Antigen Receptor T (CAR-T) Cell for Treatment of B Cell Acute Lymphoblastic Leukemia (B-ALL)
Institute of Hematology & Blood Diseases Hospital, China
Phase EARLY_PHASE1 Terminated
NCT02623582 2017-10-17
CD123 Redirected Autologous T Cells for AML
University of Pennsylvania
Phase EARLY_PHASE1 Terminated